211 results
Page 9 of 11
6-K
n5245kd vh0gkqzznj
2 May 07
Letter to Shareholders
12:00am
6-K
slnglhjs2 skfijvbs5f
13 Feb 07
Teva Reports Fourth Quarter and Full Year 2006 Results
12:00am
6-K
nfk2e
13 Nov 06
Current report (foreign)
12:00am
6-K
hgbrui1r37uxsc
7 Nov 06
Teva Reports Third Quarter 2006 Results
12:00am
6-K
ocz2cy2o06b
2 Nov 06
Teva Announces Global In-market Third Quarter Sales of Copaxone? Increased 15% to $354 Million
12:00am
6-K
ln2srfqlvb exsg
18 Oct 06
Teva Announces Planned Retirement of President & CEO In 2007; Shlomo Yanai to Succeed As President & CEO
12:00am
6-K
zl4yimv 8zdu
24 Aug 06
Teva Announces Further Steps In Global Rationalization Strategy
12:00am
6-K
80xq0jg7u7t6qgwjldqc
18 May 06
Teva Announces Fda Grants Approval of Azilect? (Rasagiline) for Parkinson's Disease
12:00am
6-K
55nw0
15 May 06
Current report (foreign)
12:00am
6-K
16n965s8ic
28 Feb 06
Teva Reports Record Sales and Net Income for the Fourth Quarter and Full Year 2005
12:00am
424B5
hcvbunp2b9 m17ltyv
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
gjuuq9l
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
ridzqfvxvn5jxr56bf1f
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
ipj64iwp
26 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
fqmw0vefp
26 Jan 06
Prospectus supplement for primary offering
12:00am
6-K
b5i9ik83
26 Jan 06
Teva Completes Acquisition of Ivax
12:00am
425
m05b g1hccr
26 Jan 06
Business combination disclosure
12:00am
424B5
oq1891w vgh5bysnso7s
26 Jan 06
Prospectus supplement for primary offering
12:00am